Frontiers in pharmacology

Keyphrases

Publications

volume 14, 2023

Yewen Xie, Fang Shao, Xuehan Duan, Jun Ding, Yongling Ning, Xiao Sun, Lei Xia, Jie Pan, Jie Chen, Shuyan He, Dong Shen, Chunjian Qi
Whole β-glucan particle attenuates AOM/DSS-induced colorectal tumorigenesis in mice via inhibition of intestinal inflammation. Frontiers in pharmacology 14 (2023)
Cheng Zhang, Xuewen Wu, Pengmin Shi, Hongyu Ma, Fei Fang, Qianlang Feng, Shuang Zhao, Ruipu Zhang, Jinyuan Huang, Xinting Xu, Weilie Xiao, Guang Cao, Xu Ji
Diterpenoids inhibit ox-LDL-induced foam cell formation in RAW264.7 cells by promoting ABCA1 mediated cholesterol efflux. Frontiers in pharmacology 14 (2023)
Zhenlong Chen, Jacob M Haus, Luisa A DiPietro, Timothy J Koh, Richard D Minshall
Neutralization of excessive CCL28 improves wound healing in diabetic mice. Frontiers in pharmacology 14 (2023)
Zhenlong Chen, Jacob M Haus, Luisa A DiPietro, Timothy J Koh, Richard D Minshall
Neutralization of excessive CCL28 improves wound healing in diabetic mice. Frontiers in pharmacology 14 (2023)
Manman Qin, Yuqing Qian, Lu Huang, Chao Zhong, Mingdong Li, Jun Yu, Huanwen Chen
Extractive electrospray ionization mass spectrometry for analytical evaluation and synthetic preparation of pharmaceutical chemicals. Frontiers in pharmacology 14 (2023)
Xinge Cui, Xin Zheng, Jianwei Ren, Hongzhong Liu, Yuan Jia, Aiguo Wu, Xiaohong Han
Development and validation of two bioanalysis methods for the determination of etimicin in human serum and urine by liquid chromatography-tandem mass spectrometry: Applications to a human pharmacokinetic and breakpoint study. Frontiers in pharmacology 14 (2023)
Hui Zheng, Yun-Zhou Shi, Jing-Tao Liang, Liang-Liang Lu, Min Chen
Modifiable factors for migraine prophylaxis: A mendelian randomization analysis. Frontiers in pharmacology 14 (2023)
Jia-Liang Zhu, Liang Hong, Shi-Qi Yuan, Xiao-Mei Xu, Jian-Rui Wei, Hai-Yan Yin
Association between glucocorticoid use and all-cause mortality in critically ill patients with heart failure: A cohort study based on the MIMIC-III database. Frontiers in pharmacology 14 (2023)
Mozaniel Santana de Oliveira, Oliviu Vostinaru, Daniela Rigano, Eloisa Helena de Aguiar Andrade
Editorial: Bioactive compounds present in essential oils: Advances and pharmacological applications. Frontiers in pharmacology 14 (2023)
Hui Zheng, Yun-Zhou Shi, Jing-Tao Liang, Liang-Liang Lu, Min Chen
Modifiable factors for migraine prophylaxis: A mendelian randomization analysis. Frontiers in pharmacology 14 (2023)
Rosy Iara Maciel Azambuja Ribeiro, Bonglee Kim
Editorial: Anti-cancer effects of natural products against reproductive cancers. Frontiers in pharmacology 14 (2023)
Myung-Eui Seo, Byung-Joo Min, Nayoon Heo, Kye Hwa Lee, Ju Han Kim
Comprehensive in vitro and in silico assessments of metabolic capabilities of 24 genomic variants of CYP2C19 using two different substrates. Frontiers in pharmacology 14 (2023)
Wenjiao Tang, Jinrong Yang, Yan Li, Li Zhang, He Li, Jie Wang, Yi Liao, Chunlan Zhang, Ying Qu, Yuhuan Zheng, Ting Niu
Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China. Frontiers in pharmacology 14 (2023)
Ying Liu, Jiake Mo, Fang Liang, Siwei Jiang, Jing Xiong, Xubiao Meng, Zhaohui Mo
Pien-tze-huang promotes wound healing in streptozotocin-induced diabetes models associated with improving oxidative stress via the Nrf2/ARE pathway. Frontiers in pharmacology 14 (2023)
Yanfang Liao, Xue Wang, Liting Huang, Hu Qian, Wei Liu
Mechanism of pyroptosis in neurodegenerative diseases and its therapeutic potential by traditional Chinese medicine. Frontiers in pharmacology 14 (2023)
Manman Qin, Yuqing Qian, Lu Huang, Chao Zhong, Mingdong Li, Jun Yu, Huanwen Chen
Extractive electrospray ionization mass spectrometry for analytical evaluation and synthetic preparation of pharmaceutical chemicals. Frontiers in pharmacology 14 (2023)
Xiaoli Zhang, Yiming Ma, Guoqing Lv, Hongying Wang
Ferroptosis as a therapeutic target for inflammation-related intestinal diseases. Frontiers in pharmacology 14 (2023)
Wenjiao Tang, Jinrong Yang, Yan Li, Li Zhang, He Li, Jie Wang, Yi Liao, Chunlan Zhang, Ying Qu, Yuhuan Zheng, Ting Niu
Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China. Frontiers in pharmacology 14 (2023)
Guangzhe Yao, Xinxin Miao, Mengxuan Wu, Zhenguo Lv, Yu Bai, Yanxu Chang, Huizi Ouyang, Jun He
Pharmacokinetics of active compounds of a Terminalia chebula Retz. Ethanolic extract after oral administration rats using UPLC-MS/MS. Frontiers in pharmacology 14 (2023)
Jia-Liang Zhu, Liang Hong, Shi-Qi Yuan, Xiao-Mei Xu, Jian-Rui Wei, Hai-Yan Yin
Association between glucocorticoid use and all-cause mortality in critically ill patients with heart failure: A cohort study based on the MIMIC-III database. Frontiers in pharmacology 14 (2023)
Mijat Božović, Milan Mladenović, Rino Ragno
Editorial: Chemical composition and antimicrobial activity of essential oils. Frontiers in pharmacology 14 (2023)
Qiuwang Zhang, Shihai Yan, Dongdong Sun, Zhirong Geng, Peixiang Zhang
Editorial: Anti-inflammatory immunopharmacology in the prevention and treatment of major chronic diseases. Frontiers in pharmacology 14 (2023)
Guangzhe Yao, Xinxin Miao, Mengxuan Wu, Zhenguo Lv, Yu Bai, Yanxu Chang, Huizi Ouyang, Jun He
Pharmacokinetics of active compounds of a Terminalia chebula Retz. Ethanolic extract after oral administration rats using UPLC-MS/MS. Frontiers in pharmacology 14 (2023)
Xu Yan, Tianjiao Lin, Qingyun Zhu, Yushi Zhang, Zhimin Song, Xinting Pan
Naringenin protects against acute pancreatitis-associated intestinal injury by inhibiting NLRP3 inflammasome activation via AhR signaling. Frontiers in pharmacology 14 (2023)
Ying Liu, Jiake Mo, Fang Liang, Siwei Jiang, Jing Xiong, Xubiao Meng, Zhaohui Mo
Pien-tze-huang promotes wound healing in streptozotocin-induced diabetes models associated with improving oxidative stress via the Nrf2/ARE pathway. Frontiers in pharmacology 14 (2023)
Yasuhiko Koga, Yosuke Kamide, Takeshi Hisada, Tamotsu Ishizuka
Editorial: Pathophysiological and clinical advances in asthmatic inflammation from the nasopharynx to the peripheral airway in the respiratory tract systems. Frontiers in pharmacology 14 (2023)
Ruifei Shao, Wei Li, Rui Chen, Kunlin Li, Yu Cao, Guobing Chen, Lihong Jiang
Exploring the molecular mechanism of notoginsenoside R1 in sepsis-induced cardiomyopathy based on network pharmacology and experiments validation. Frontiers in pharmacology 14 (2023)
Pierre Sauton, Jerome Jeanblanc, Farid Benzerouk, Fabien Gierski, Mickael Naassila
Sex-specific decision-making impairments and striatal dopaminergic changes after binge drinking history in rats. Frontiers in pharmacology 14 (2023)
Wenbo Qi, Dayong Xi, Yuping Bai, Le Liu, Yanling Ma, Zhenyu Yin, Hao Chen
Case Report: Chemotherapy-free treatment with camrelizumab and anlotinib for elderly patients with KRAS and TP53 mutated advanced lung cancer. Frontiers in pharmacology 14 (2023)
Yamin Jie, Jianing Wu, Dongxue An, Man Li, Hongjiang He, Duo Wang, Anxin Gu, Mingyan E
Molecular characterization based on tumor microenvironment-related signatures for guiding immunotherapy and therapeutic resistance in lung adenocarcinoma. Frontiers in pharmacology 14 (2023)
Cheng Zhang, Xuewen Wu, Pengmin Shi, Hongyu Ma, Fei Fang, Qianlang Feng, Shuang Zhao, Ruipu Zhang, Jinyuan Huang, Xinting Xu, Weilie Xiao, Guang Cao, Xu Ji
Diterpenoids inhibit ox-LDL-induced foam cell formation in RAW264.7 cells by promoting ABCA1 mediated cholesterol efflux. Frontiers in pharmacology 14 (2023)
Myung-Eui Seo, Byung-Joo Min, Nayoon Heo, Kye Hwa Lee, Ju Han Kim
Comprehensive in vitro and in silico assessments of metabolic capabilities of 24 genomic variants of CYP2C19 using two different substrates. Frontiers in pharmacology 14 (2023)
Ja Yeon Park, Woo Yong Park, Gahee Song, Se Jin Jung, Beomsu Kim, Minji Choi, Sang Hee Kim, Jinbong Park, Hyun Jeong Kwak, Kwang Seok Ahn, Jun Hee Lee, Jae-Young Um
Panax ginseng C.A. meyer alleviates benign prostatic hyperplasia while preventing finasteride-induced side effects. Frontiers in pharmacology 14 (2023)
Nelson Chong, Paola Campagnolo
Editorial: Circadian biology, cardiovascular function and disease. Frontiers in pharmacology 14 (2023)
Qiuwang Zhang, Shihai Yan, Dongdong Sun, Zhirong Geng, Peixiang Zhang
Editorial: Anti-inflammatory immunopharmacology in the prevention and treatment of major chronic diseases. Frontiers in pharmacology 14 (2023)
Xu Yan, Tianjiao Lin, Qingyun Zhu, Yushi Zhang, Zhimin Song, Xinting Pan
Naringenin protects against acute pancreatitis-associated intestinal injury by inhibiting NLRP3 inflammasome activation via AhR signaling. Frontiers in pharmacology 14 (2023)
Yijun Liu, Fuhu Song, Zhi Li, Liang Chen, Ying Xu, Huiyan Sun, Yi Chang
A comprehensive tool for tumor precision medicine with pharmaco-omics data analysis. Frontiers in pharmacology 14 (2023)
Xiuying Zhang, Qilei Chen, Jia Zhao, Wei Zhao, Ni Fan, Yu Wang, Hubiao Chen, Jianhui Rong
A four-compound remedy AGILe protected H9c2 cardiomyocytes against oxygen glucose deprivation via targeting the TNF-α/NF-κB pathway: Implications for the therapy of myocardial infarction. Frontiers in pharmacology 14 (2023)
Wenbo Qi, Dayong Xi, Yuping Bai, Le Liu, Yanling Ma, Zhenyu Yin, Hao Chen
Case Report: Chemotherapy-free treatment with camrelizumab and anlotinib for elderly patients with KRAS and TP53 mutated advanced lung cancer. Frontiers in pharmacology 14 (2023)
Ruifei Shao, Wei Li, Rui Chen, Kunlin Li, Yu Cao, Guobing Chen, Lihong Jiang
Exploring the molecular mechanism of notoginsenoside R1 in sepsis-induced cardiomyopathy based on network pharmacology and experiments validation. Frontiers in pharmacology 14 (2023)
Xinge Cui, Xin Zheng, Jianwei Ren, Hongzhong Liu, Yuan Jia, Aiguo Wu, Xiaohong Han
Development and validation of two bioanalysis methods for the determination of etimicin in human serum and urine by liquid chromatography-tandem mass spectrometry: Applications to a human pharmacokinetic and breakpoint study. Frontiers in pharmacology 14 (2023)
Kouzhu Zhu, Xiaoliang Ding, Zhiyao Chen, Qinhua Xi, Xueqin Pang, Weichang Chen, Liyan Miao
Association between genetic variants and development of antibodies to infliximab: A cross-sectional study in Chinese patients with Crohn's disease. Frontiers in pharmacology 14 (2023)
Xiuying Zhang, Qilei Chen, Jia Zhao, Wei Zhao, Ni Fan, Yu Wang, Hubiao Chen, Jianhui Rong
A four-compound remedy AGILe protected H9c2 cardiomyocytes against oxygen glucose deprivation via targeting the TNF-α/NF-κB pathway: Implications for the therapy of myocardial infarction. Frontiers in pharmacology 14 (2023)
Ja Yeon Park, Woo Yong Park, Gahee Song, Se Jin Jung, Beomsu Kim, Minji Choi, Sang Hee Kim, Jinbong Park, Hyun Jeong Kwak, Kwang Seok Ahn, Jun Hee Lee, Jae-Young Um
Panax ginseng C.A. meyer alleviates benign prostatic hyperplasia while preventing finasteride-induced side effects. Frontiers in pharmacology 14 (2023)
Monika Lassanova, Stefan Lassan, Silvia Liskova, Tomas Tesar, Monika Cicova
Analysis of spontaneous reports of suspected adverse reactions after vaccination against COVID-19 in Slovakia. Frontiers in pharmacology 14 (2023)
Taiba A Al-Arbeed, Waleed M Renno, Jassim M Al-Hassan
Neuroregeneration of injured peripheral nerve by fraction B of catfish epidermal secretions through the reversal of the apoptotic pathway and DNA damage. Frontiers in pharmacology 14 (2023)
Yanfang Liao, Xue Wang, Liting Huang, Hu Qian, Wei Liu
Mechanism of pyroptosis in neurodegenerative diseases and its therapeutic potential by traditional Chinese medicine. Frontiers in pharmacology 14 (2023)
Yewen Xie, Fang Shao, Xuehan Duan, Jun Ding, Yongling Ning, Xiao Sun, Lei Xia, Jie Pan, Jie Chen, Shuyan He, Dong Shen, Chunjian Qi
Whole β-glucan particle attenuates AOM/DSS-induced colorectal tumorigenesis in mice via inhibition of intestinal inflammation. Frontiers in pharmacology 14 (2023)
Yijun Liu, Fuhu Song, Zhi Li, Liang Chen, Ying Xu, Huiyan Sun, Yi Chang
A comprehensive tool for tumor precision medicine with pharmaco-omics data analysis. Frontiers in pharmacology 14 (2023)
Xiaoli Zhang, Yiming Ma, Guoqing Lv, Hongying Wang
Ferroptosis as a therapeutic target for inflammation-related intestinal diseases. Frontiers in pharmacology 14 (2023)